🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT06673355
Active, not recruiting Not applicable

"Comparative Study of Supra-Structure Materials in Full-Arch Implant Prosthetics: a Randomized Clinical Trial"

NCT06673355 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2024-07-08
Last updated
2024-11-04

Condition(s) studied

Edentulous Mandible

Investigational drug(s) / intervention(s)

dental implant prosthesis

dental implant prosthesis: patients will receive frameworks made of high-performance polymer filled with nano zirconia and carbon

Study summary

after the implants' osseointegration period (4 months), digital scans will be taken for the implant positions and the STL files will be stored and sent for the CAD software to design a full arch restoration. Two types will be constructed, Group I patients will receive porcelain fused to titanium frameworks, and Group II will receive a framework made of high-performance polymer filled with nano-zirconia and carbon. After the installation of the frameworks, the bone height changes and the wear of the occlusal surfaces will be monitored at baseline, after 6 months and 12 months post insertion.

Eligibility

Sex
MALE
Min age
25 Years
Max age
55 Years
Healthy volunteers
Accepted
Inclusion Criteria: * non-smokers * patients with adequate bone height and width * patients with good oral hygiene and healthy gingiva Exclusion Criteria: * smokers * patients with inadequate bone height and width * non-compliant patients * patients with systemic diseases that will affect bone remodelling

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Misr University for Science and Technology Giza Giza Governorate

More Misr University for Science and Technology trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06673355 on ClinicalTrials.gov ↗ ← All trials in Egypt